BCLS Acquisition Corp. (Nasdaq: BLSA) is a blank-check company sponsored by Bain Capital Life Sciences, the healthcare-focused investment arm of global private equity firm Bain Capital. The company completed its initial public offering in 2020, targeting acquisition opportunities in the biopharmaceutical, medical device, and broader life sciences sectors. The 10-Q filed on May 14, 2021, covering the quarter ended March 31, 2021, reflects the company's status as an active pre-combination vehicle engaged in evaluating potential business combination targets. Bain Capital Life Sciences brings significant sector expertise in biotech and healthcare investing to its sponsor role. For complete filing history, deal timelines, and SPAC analytics on BLSA, sign up for full data access at SpacDesk.